Ramdas Borhade: IL-17, Endothelial Activation and Thrombosis Prediction in Cancer
Ramdas Borhade, Deputy General Manager at Murali Krishna Pharma PVT LTD, shared on LinkedIn about a recent article by Dimitra Karagkouni et al, published in Science Translational Medicine, adding:
”Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation | Science Translational Medicine.”
Title: Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation
Authors: Dimitra Karagkouni, Marisa A. Brake, Rushad Patell, Anna Falanga, Marina Marchetti, Laura Russo, Simon Mantha, Donna Neuberg, Thita Chiasakul, Marc Carrier, Philip S. Wells, Robert E. Gerszten, Robert Flaumenhaft, Daniel Hui, Ioannis S. Vlachos, Sol Schulman, Jeffrey I. Zwicker
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 19, 2026, 18:00George Harston: How AI Is Supporting the Next Generation of Acute Stroke Care in AHA 2026 Guidelines
-
Jun 19, 2026, 17:49Jennifer Beauchamp: Exploring the New Era of Stroke Care at the 16th Annual Yatsu Day Symposium
-
Jun 19, 2026, 17:44Brian A Beh: How A Lacunar Stroke Changed Me
-
Jun 19, 2026, 17:40Cameron Bryer: Returning to Work After a Young Stroke Is Challenging but Possible
-
Jun 19, 2026, 17:33Jackie Pueppke: The AHA’s Stroke Cards Remind Me How Quickly Action Saved My Life
-
Jun 19, 2026, 17:18Jasmin Hefendehl: Ischemic Stroke Reveals a Protective Microglial Response in Alzheimer’s Pathology
-
Jun 19, 2026, 17:00What Classical Haematologists Need to Know About Female Reproductive Health – The Lancet Haematology
-
Jun 19, 2026, 16:24Paritosh Garg: Management of ITP in Pregnancy – What Changed My Practice?
-
Jun 19, 2026, 15:16Jecko Thachil: The Overlooked Impact of Iron Deficiency Without Anaemia